Regorafenib Enhances Lethality of Sildenafil and Curcumin in Colorectal Cancer Cells
In the United States, more than 130,000 people will be diagnosed with colorectal cancer (CRC) each year and an estimated 50,000 people will die from the disease. Standard of care (SOC) therapies for CRC combine multiple cytotoxic chemotherapeutic drugs. These combinations have varying degrees of eff...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
VCU Scholars Compass
2019
|
| Subjects: | |
| Online Access: | https://scholarscompass.vcu.edu/etd/5975 https://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=7055&context=etd |